Selected research
Industry Research
Diabetic Retinopathy Screening Software Industry Research Report 2026
Market perspective
The global Diabetic Retinopathy Screening Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Diabetic Retinopathy Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Diabetic Retinopathy Screening Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Diabetic Retinopathy Screening Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Diabetic Retinopathy Screening Software include Retmarker, Retina Labs, Eyenuk, Inc., RetinaLyze, Intelligent Retinal Imaging Systems(IRIS), Retina AI, Optomed, RetinaRisk and InHealth Intelligence, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Diabetic Retinopathy Screening Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Diabetic Retinopathy Screening Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diabetic Retinopathy Screening Software Market by Company
Retmarker
Retina Labs
Eyenuk, Inc.
RetinaLyze
Intelligent Retinal Imaging Systems(IRIS)
Retina AI
Optomed
RetinaRisk
InHealth Intelligence
CSIRO
NEC Care
Diabetic Retinopathy Screening Software Segment by Type
Cloud Based
On-Premise
Diabetic Retinopathy Screening Software Segment by Application
Hospital Eye Diagnosis
Personal Screening
Medical Research
Diabetic Retinopathy Screening Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Diabetic Retinopathy Screening Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-Premise
Applications
- Hospital Eye Diagnosis
- Personal Screening
- Medical Research
Companies covered
- Retmarker
- Retina Labs
- Eyenuk, Inc.
- RetinaLyze
- Intelligent Retinal Imaging Systems(IRIS)
- Retina AI
- Optomed
- RetinaRisk
- InHealth Intelligence
- CSIRO
- NEC Care
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Diabetic Retinopathy Screening Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud Based
- 2.2.3 On-Premise
- 2.3 Diabetic Retinopathy Screening Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Eye Diagnosis
- 2.3.3 Personal Screening
- 2.3.4 Medical Research
- 2.4 Assumptions and Limitations
3 Diabetic Retinopathy Screening Software Breakdown Data by Type
- 3.1 Global Diabetic Retinopathy Screening Software Historic Market Size by Type (2021-2026)
- 3.2 Global Diabetic Retinopathy Screening Software Forecasted Market Size by Type (2027-2032)
4 Diabetic Retinopathy Screening Software Breakdown Data by Application
- 4.1 Global Diabetic Retinopathy Screening Software Historic Market Size by Application (2021-2026)
- 4.2 Global Diabetic Retinopathy Screening Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Diabetic Retinopathy Screening Software Market Perspective (2021-2032)
- 5.2 Global Diabetic Retinopathy Screening Software Growth Trends by Region
- 5.2.1 Global Diabetic Retinopathy Screening Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Diabetic Retinopathy Screening Software Historic Market Size by Region (2021-2026)
- 5.2.3 Diabetic Retinopathy Screening Software Forecasted Market Size by Region (2027-2032)
- 5.3 Diabetic Retinopathy Screening Software Market Dynamics
- 5.3.1 Diabetic Retinopathy Screening Software Industry Trends
- 5.3.2 Diabetic Retinopathy Screening Software Market Drivers
- 5.3.3 Diabetic Retinopathy Screening Software Market Challenges
- 5.3.4 Diabetic Retinopathy Screening Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Diabetic Retinopathy Screening Software Players by Revenue
- 6.1.1 Global Top Diabetic Retinopathy Screening Software Players by Revenue (2021-2026)
- 6.1.2 Global Diabetic Retinopathy Screening Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Diabetic Retinopathy Screening Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Diabetic Retinopathy Screening Software Head Office and Area Served
- 6.4 Global Diabetic Retinopathy Screening Software Players, Product Type & Application
- 6.5 Global Diabetic Retinopathy Screening Software Manufacturers Established Date
- 6.6 Global Diabetic Retinopathy Screening Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 7.2 North America Diabetic Retinopathy Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 7.4 North America Diabetic Retinopathy Screening Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 8.2 Europe Diabetic Retinopathy Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 8.4 Europe Diabetic Retinopathy Screening Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 9.2 Asia-Pacific Diabetic Retinopathy Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Diabetic Retinopathy Screening Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 10.2 South America Diabetic Retinopathy Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 10.4 South America Diabetic Retinopathy Screening Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Diabetic Retinopathy Screening Software Market Size (2021-2032)
- 11.2 Middle East & Africa Diabetic Retinopathy Screening Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Diabetic Retinopathy Screening Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Diabetic Retinopathy Screening Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Retmarker
- 12.1.1 Retmarker Company Information
- 12.1.2 Retmarker Business Overview
- 12.1.3 Retmarker Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.1.4 Retmarker Diabetic Retinopathy Screening Software Product Portfolio
- 12.1.5 Retmarker Recent Developments
- 12.2 Retina Labs
- 12.2.1 Retina Labs Company Information
- 12.2.2 Retina Labs Business Overview
- 12.2.3 Retina Labs Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.2.4 Retina Labs Diabetic Retinopathy Screening Software Product Portfolio
- 12.2.5 Retina Labs Recent Developments
- 12.3 Eyenuk, Inc.
- 12.3.1 Eyenuk, Inc. Company Information
- 12.3.2 Eyenuk, Inc. Business Overview
- 12.3.3 Eyenuk, Inc. Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.3.4 Eyenuk, Inc. Diabetic Retinopathy Screening Software Product Portfolio
- 12.3.5 Eyenuk, Inc. Recent Developments
- 12.4 RetinaLyze
- 12.4.1 RetinaLyze Company Information
- 12.4.2 RetinaLyze Business Overview
- 12.4.3 RetinaLyze Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.4.4 RetinaLyze Diabetic Retinopathy Screening Software Product Portfolio
- 12.4.5 RetinaLyze Recent Developments
- 12.5 Intelligent Retinal Imaging Systems(IRIS)
- 12.5.1 Intelligent Retinal Imaging Systems(IRIS) Company Information
- 12.5.2 Intelligent Retinal Imaging Systems(IRIS) Business Overview
- 12.5.3 Intelligent Retinal Imaging Systems(IRIS) Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.5.4 Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Product Portfolio
- 12.5.5 Intelligent Retinal Imaging Systems(IRIS) Recent Developments
- 12.6 Retina AI
- 12.6.1 Retina AI Company Information
- 12.6.2 Retina AI Business Overview
- 12.6.3 Retina AI Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.6.4 Retina AI Diabetic Retinopathy Screening Software Product Portfolio
- 12.6.5 Retina AI Recent Developments
- 12.7 Optomed
- 12.7.1 Optomed Company Information
- 12.7.2 Optomed Business Overview
- 12.7.3 Optomed Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.7.4 Optomed Diabetic Retinopathy Screening Software Product Portfolio
- 12.7.5 Optomed Recent Developments
- 12.8 RetinaRisk
- 12.8.1 RetinaRisk Company Information
- 12.8.2 RetinaRisk Business Overview
- 12.8.3 RetinaRisk Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.8.4 RetinaRisk Diabetic Retinopathy Screening Software Product Portfolio
- 12.8.5 RetinaRisk Recent Developments
- 12.9 InHealth Intelligence
- 12.9.1 InHealth Intelligence Company Information
- 12.9.2 InHealth Intelligence Business Overview
- 12.9.3 InHealth Intelligence Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.9.4 InHealth Intelligence Diabetic Retinopathy Screening Software Product Portfolio
- 12.9.5 InHealth Intelligence Recent Developments
- 12.10 CSIRO
- 12.10.1 CSIRO Company Information
- 12.10.2 CSIRO Business Overview
- 12.10.3 CSIRO Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.10.4 CSIRO Diabetic Retinopathy Screening Software Product Portfolio
- 12.10.5 CSIRO Recent Developments
- 12.11 NEC Care
- 12.11.1 NEC Care Company Information
- 12.11.2 NEC Care Business Overview
- 12.11.3 NEC Care Revenue in Diabetic Retinopathy Screening Software Business (2021-2026)
- 12.11.4 NEC Care Diabetic Retinopathy Screening Software Product Portfolio
- 12.11.5 NEC Care Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst